Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA.
Animals
Animals, Genetically Modified
Antigens, Bacterial
/ metabolism
Atherosclerosis
/ microbiology
Bacterial Proteins
/ metabolism
Drosophila melanogaster
/ anatomy & histology
Eye
/ metabolism
Female
Helicobacter pylori
/ metabolism
Humans
Hypercholesterolemia
/ microbiology
Lipoproteins, LDL
/ blood
Male
Protein Binding
Receptors, LDL
/ metabolism
Virulence Factors
/ metabolism
CagA
Cardiovascular disease
Helicobacter pylori
Hypercholesterolemia
Low-density lipoprotein
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
04 06 2021
04 06 2021
Historique:
received:
25
03
2021
accepted:
30
03
2021
pubmed:
13
4
2021
medline:
21
7
2021
entrez:
12
4
2021
Statut:
ppublish
Résumé
Helicobacter pylori (H. pylori) infection mainly causes gastroduodenal diseases, including chronic gastritis, peptic ulcer disease and gastric cancer. In recent years, several studies have demonstrated that infection with H. pylori, especially strains harboring the virulence factor CagA (cytotoxin-associated gene A), contribute to the development of non-gastric systemic diseases, including hypercholesterolemia and atherosclerotic cardiovascular diseases. However, mechanisms underlying this association has not been defined. In this study, we carried out a large-scale genetic screen using Drosophila and identified a novel CagA target low-density lipoprotein receptor (LDLR), which aids in the clearance of circulating LDL. We showed that CagA physically interacted with LDLR via its carboxy-terminal region and inhibited LDLR-mediated LDL uptake into cells. Since deficiency of LDLR-mediated LDL uptake has been known to increase plasma LDL and accelerate atherosclerosis, our findings may provide a novel mechanism for the association between infection with CagA-positive H. pylori and hypercholesterolemia leading to atherosclerotic cardiovascular diseases.
Identifiants
pubmed: 33845309
pii: S0006-291X(21)00582-9
doi: 10.1016/j.bbrc.2021.03.170
pii:
doi:
Substances chimiques
Antigens, Bacterial
0
Bacterial Proteins
0
Lipoproteins, LDL
0
Receptors, LDL
0
Virulence Factors
0
cagA protein, Helicobacter pylori
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
192-198Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.